TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC)—Background.

Phase Iii ◽

Phase Iii Trial ◽

Double Blinded

981O Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin, fluorouracil, and leucovorin (FOLFOX) versus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC): A randomised phase III trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1097 ◽

2020 ◽

Vol 31 ◽

pp. S688 ◽

Cited By ~ 1

Author(s):

M. Shi ◽

Q. Li ◽

M. He ◽

R. Guo

Keyword(s):

Unresectable Hepatocellular Carcinoma

Transarterial Chemoembolization ◽

Hepatic Arterial Infusion ◽

Hepatic Arterial Infusion Chemotherapy ◽

Phase Iii ◽

Arterial Infusion ◽

Phase Iii Trial ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy ◽

G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma

Journal of Hepatology ◽

10.1016/s0168-8278(15)30007-6 ◽

2015 ◽

Vol 62 ◽

pp. S189-S190 ◽

Cited By ~ 3

Author(s):

J.-W. Park ◽

A.-L. Cheng ◽

M. Kudo ◽

J.H. Park ◽

P.-C. Liang ◽

...

Keyword(s):

Transcatheter Arterial Chemoembolization ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Arterial Chemoembolization

Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)

European Journal of Cancer ◽

10.1016/j.ejca.2008.01.004 ◽

2008 ◽

Vol 44 (4) ◽

pp. 528-538 ◽

Cited By ~ 55

Author(s):

M. Doffoël ◽

F. Bonnetain ◽

O. Bouché ◽

D. Vetter ◽

A. Abergel ◽

...

Keyword(s):

Phase Iii ◽

Phase Iii Trial ◽

Cirrhotic Patients ◽

Cancérologie Digestive

Multicenter randomized phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolization (TLC) for unresectable hepatocellular carcinoma (HCC) in cirrhotic patients

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4006 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4006-4006 ◽

Cited By ~ 2

Author(s):

M. Doffoel ◽

D. Vetter ◽

O. Bouche ◽

F. Bonnetain ◽

A. Abergel ◽

...

Keyword(s):

Phase Iii ◽

Phase Iii Trial ◽

Cirrhotic Patients

Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma

European Journal of Cancer ◽

10.1016/j.ejca.2011.05.007 ◽

2011 ◽

Vol 47 (14) ◽

pp. 2117-2127 ◽

Cited By ~ 283

Author(s):

Masatoshi Kudo ◽

Kazuho Imanaka ◽

Nobuyuki Chida ◽

Kohei Nakachi ◽

Won-Young Tak ◽

...

Keyword(s):

Phase Iii ◽

Korean Patients ◽

Phase Iii Study

Faculty Opinions recommendation of Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3358963.3047062 ◽

2010 ◽

Author(s):

Elfyn Thomas

Keyword(s):

Subarachnoid Hemorrhage ◽

Magnesium Sulphate ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Phase Iii ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Intravenous Magnesium ◽

Double Blinded

Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma

10.1002/14651858.cd010903 ◽

2013 ◽

Author(s):

Wenbo Shao ◽

Jinlong Song

Keyword(s):

Drug Eluting

The efficacy and safety of lenvatinib in patients who did not meet the inclusion criteria of the phase III trial (REFLECT trial) and those with BCLC Stage B hepatocellular carcinoma: A nationwide multicenter study in Japan

Annals of Oncology ◽

10.1093/annonc/mdz247.078 ◽

2019 ◽

Vol 30 ◽

pp. v289

Author(s):

A. Sakamoto ◽

M. Kurosaki ◽

K. Tsuchiya ◽

T. Abe ◽

C. Ogawa ◽

...

Keyword(s):

Multicenter Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Inclusion Criteria ◽

Phase Iii Trial

Yttrium-90 radioembolisation versus transarterial chemoembolisation for unresectable hepatocellular carcinoma: a retrospective comparative analysis according to BCLC classification

HPB ◽

10.1016/j.hpb.2017.02.435 ◽

2017 ◽

Vol 19 ◽

pp. S191

Author(s):

Marco Massani ◽

Tommaso Stecca ◽

Giovanni Pirozzolo ◽

Cesare Ruffolo ◽

Davide Barbisan ◽

...

Keyword(s):

Comparative Analysis ◽

Yttrium 90

Effect of Transarterial Chemoembolisation in Unresectable Hepatocellular Carcinoma with Portal Vein Tumour Thrombosis: Single-centre Study

Hong Kong Journal of Radiology ◽

10.12809/hkjr1515316 ◽

2015 ◽

Vol 18 (4) ◽

pp. 277-281

Author(s):

KL Siu ◽

PY Chu ◽

HW Lau ◽

CX Chan ◽

SK Ip

Keyword(s):

Portal Vein ◽

Single Centre ◽

Centre Study ◽

Single Centre Study